LAUSR

Objectives: To determine the Quality of Prescribing in Patients with Hypertension using Prescription Quality Index (PQI) Tool. Ensure the Rational Use of Anti-Hypertensive drugs. Methods: Prospective study of Anti-Hypertensive drugs should be conducted on 150 consecutive patients admitted in tertiary care Hospital. The duration of the study will be of 10 months. The prescriptions of the patient who are treated during the course of the study will be audited prospectively using a specially designed form to record the required information. Results: Total of 150 patients 86 were male and 64 were female.This study the age group who receive more Anti Hypertensive drugs are between 56-65 years(40%), In this study who are found with single comorbid condition is (41.3%), Multiple comorbid condition is (22.7%), In This study stages of Hypertension was validated, Pre Hypertensive (88%),Stage 1(57.3%),Stage 2 (34.7%). In This study different classes of drugs commonly used were Diuretics (72%).In the present study it was observed that the higher rates of (56.7%) received dual therapy for Hypertension than mono therapy (43.3%) and compared. Conclusion: Angiotensin II receptor blockers (ARBs) are more effective in slowing the progression of chronic kidney disease (CKD) than other antihypertensive regimens. The PQI is a comprehensive tool which is valid and reliable for measuring quality of prescribing in chronic disease like hypertension in Indian settings. PQI can be used for assessment and comparison of quality of prescribing in different clinical settings at different health care levels.